Are synthetic contrast-enhanced breast MRI images as good as the real thing?

synthetic contrast-enhanced breast MRI

MRI scans in a 55-year-old woman with right invasive ductal carcinoma (left panel) and a 67-year-old woman with right invasive ductal carcinoma (right panel) show failed enhancement of the index lesion (arrow) on the simulated (i.e., synthetic) contrast-enhanced MRI scans.

Image courtesy of Radiology.

Synthesizing contrast-enhanced imaging from pre-contrast inputs using deep learning can help overcome obstacles involved in the use of GBCAs.

Can cold-cathode X-ray combined with teleradiology and AI eliminate health disparities?

The Nanox ARC cold-cathode, tomosynthesis 3D X-ray system is currently pending FDA clearance. If cleared, it would be the first device of its kind to offer cold-cathode X-ray tube technology and the ability to slice through the anatomy in images similar to CT scans to aid diagnosis. The new type of tube also could greatly reduce the size and weight of X-ray systems. The vendor sees this system as key to its larger plan to address health disparities and access to imaging world-wide. #Nanox

The Nanox ARC cold-cathode, tomosythesis 3D X-ray system is currently pending FDA clearance. If cleared, it would be the first device of its kind to offer cold-cathode X-ray tube technology and the ability to slice through the anatomy in images similar to CT scans. The new tube type also could greatly reduce the size and weight of X-ray systems. The vendor sees this system as key to its larger plan to address health disparities and access to imaging worldwide.

The Israeli vendor Nanox says it has a vision for the future of healthcare. It seeks to address health disparities and access challenges with a new business model and innovative package of technologies. Hurdles loom, but opportunities abound. 

Design by Adaptive Theme